MétaCan
Menu
Back to cohort
Record W2599767976 · doi:10.1093/ehjci/eux152

1152Second generation cryoballoon ablation in paroxysmal atrial fibrillation patients: 24 month safety and efficacy from the STOP-AF post approval study

2017· article· en· W2599767976 on OpenAlexaffabout
BP Knight, P. G. Novak, Robert Sangrigoli, J. Champagne, M. Dubuc, Sw. Adler, Jt. Svinarich, Vidal Essebag, Rb. Hokanson, Fred Kueffer, Sushil K. Jain, Rm. John, Moussa Mansour

Bibliographic record

VenueEP Europace · 2017
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsMcGill University Health CentreMontreal Heart InstituteRoyal Jubilee Hospital
Fundersnot available
KeywordsMedicineParoxysmal atrial fibrillationAtrial fibrillationCardiologyInternal medicineAblation

Abstract

fetched live from OpenAlex

On behalf of: STOP AF PAS Study Investigators Funding Acknowledgements: Medtronic Background/Introduction: There is limited long-term, multicenter data reporting outcomes after catheter ablation for paroxysmal atrial fibrillation (pAF) using the second generation cryoballoon (CB2). Purpose: The purpose of this interim analysis was to report the safety and efficacy through 24 months from the largest prospective multi-center trial evaluating cryoballoon ablation using the CB2 in the United States and Canada. Methods: The STOP-AF post approval study is a prospective, multi-center, non-randomized study designed to provide long-term safety and efficacy data for cryoballoon ablation. Enrollment is complete with 344 eligible subjects with drug-refractory, recurrent symptomatic pAF undergoing CB2 ablation. 98.5% of subjects have been followed for at least 2 years. Procedure related safety data is presented, and freedom from atrial fibrillation (AF) and symptomatic atrial flutter (AFL) / atrial tachycardia (AT) at 1-year and 2-years is presented. Documented AF lasting longer than 30 seconds and/or a repeat ablation after the 90-day blanking period were considered treatment failures. Results: Acute pulmonary vein isolation (PVI) was achieved in 99.4% (342/344) of patients. Mean follow-up is 27 ± 9 months. Freedom from AF was 82.1% (95% CI: 77.6% to 85.8%) at 12 months and 75.4% (95% CI: 70.3% to 79.8%) at 24 months. Freedom from AF and symptomatic AFL/AT was 79.5%% (95% CI: 74.8% to 83.4%) at 12 months and 72.4% (95% CI: 67.2% to 77.0%) at 24 months. Phrenic nerve injury (PNI) was unresolved at hospital discharge in 11 patients (3.2%). PNI resolved in 10/11 patients (mean time to resolution = 209 days) and was still present after 24 months in 1 patient (0.3%). Other major events included: cerebrovascular accident (0.3%), asymptomatic pulmonary vein stenosis (0.6%), pericardial effusion (0.9%), and hemoptysis (0.9%). No device or procedure related deaths occurred. Conclusion: This is the largest multicenter study to report safety and efficacy of PVI using CB2 at 24 months follow-up. Freedom from AF of 82.1% at 12 months and 75.4% at 24 months, and freedom from all atrial arrhythmias of 79.5% at 12 months and 72.4% at 24 months. PNI ongoing beyond 12 months is observed in only one patient.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.304
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueEP EuropaceSame topicAtrial Fibrillation Management and OutcomesFrench-language works237,207